NSE:ASTRAZEN
AstraZeneca Pharma India Limited
- Stock
Last Close
5,435.20
06/05 10:00
Market Cap
157.97B
Beta: 0.39
Volume Today
10.94K
Avg: 4.82K
PE Ratio
108.89
PFCF: 7,021.31
Dividend Yield
0.24%
Payout:0%
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 905.63M - | 909.44M 0.42% | 814.30M 10.46% | 672.24M 17.45% | 854.34M 27.09% | 1.16B 35.34% | 1.42B 22.49% | 1.62B 14.72% | 1.50B 7.67% | 1.65B 10.14% | |
average payables | 1.00B - | 1.11B 10.27% | 1.03B 6.89% | 651.99M 36.67% | 655.55M 0.55% | 1.32B 101.01% | 1.89B 43.40% | 1.94B 2.69% | 1.83B 5.58% | 2.08B 13.51% | |
average receivables | 743.08M - | 1.20B 61.38% | 1.33B 10.96% | 967.59M 27.28% | 718.62M 25.73% | 776.60M 8.07% | 934.05M 20.27% | 934.08M 0.00% | 947.51M 1.44% | 1.03B 8.65% | |
book value per share | 68.64 - | 60.30 12.14% | 62.41 3.49% | 72.18 15.67% | 98.77 36.84% | 120.32 21.82% | 145.78 21.16% | 182.47 25.17% | 204.56 12.11% | 235.49 15.12% | |
capex per share | -8.65 - | -9.52 10.04% | -3.62 62.00% | -2.25 37.70% | -2.51 11.44% | -7.48 197.61% | -5.69 23.92% | -3.08 45.78% | -3.85 24.77% | -3.41 11.43% | |
capex to depreciation | -2.14 - | -1.56 27.09% | -0.52 66.68% | -0.36 31.39% | -0.43 19.65% | -1.25 194.02% | -0.77 38.90% | -0.39 48.99% | -0.57 45.38% | -0.52 7.68% | |
capex to operating cash flow | 26.79 - | 0.52 98.06% | -0.16 130.47% | -0.15 7.31% | -0.71 385.67% | -0.34 52.42% | -0.16 52.15% | -0.07 54.76% | -0.10 29.70% | -0.15 53.13% | |
capex to revenue | -0.05 - | -0.05 11.14% | -0.02 66.15% | -0.01 39.21% | -0.01 5.30% | -0.03 133.35% | -0.02 33.39% | -0.01 44.22% | -0.01 25.23% | -0.01 28.86% | |
cash per share | 35.07 - | 9.58 72.70% | 30.48 218.32% | 45.82 50.32% | 50.26 9.70% | 69.30 37.86% | 101 45.75% | 143.20 41.78% | 184.29 28.70% | 204.44 10.93% | |
days of inventory on hand | 194.01 - | 154.90 20.16% | 131.60 15.04% | 104.37 20.69% | 184.75 77.01% | 159.87 13.46% | 180.28 12.76% | 176.46 2.12% | 143.18 18.86% | 151.69 5.95% | |
days payables outstanding | 222.60 - | 200.12 10.10% | 162.30 18.90% | 64.68 60.15% | 155.67 140.66% | 227.69 46.27% | 228.93 0.54% | 196.97 13.96% | 192.03 2.51% | 181.73 5.36% | |
days sales outstanding | 67.50 - | 118.46 75.49% | 78.97 33.33% | 53.86 31.80% | 40.98 23.91% | 45.72 11.55% | 41.95 8.23% | 41.18 1.85% | 44.53 8.15% | 39.16 12.06% | |
debt to assets | 0.00 - | 0.00 0.97% | 0.02 - | 0.02 6.51% | 0.01 35.71% | 0.01 27.30% | |||||
debt to equity | 0.00 - | 0.00 13.82% | 0.03 - | 0.03 18.08% | 0.02 36.59% | 0.01 27.39% | |||||
dividend yield | 0.00 - | 0.00 59.76% | 0.00 17.93% | 0.00 213.83% | |||||||
earnings yield | -0.00 - | -0.01 4,812.87% | 0.00 120.12% | 0.01 473.85% | 0.01 5.54% | 0.01 1.84% | 0.01 10.94% | 0.01 3.21% | 0.01 22.14% | 0.01 26.46% | |
enterprise value | 27.58B - | 23.01B 16.56% | 28.81B 25.19% | 23.37B 18.88% | 22.34B 4.38% | 48.54B 117.25% | 59.38B 22.33% | 71.83B 20.97% | 59.40B 17.31% | 76.38B 28.59% | |
enterprise value over ebitda | -94.77 - | -486.14 412.98% | 172.52 135.49% | 53.21 69.15% | 44.08 17.17% | 68.14 54.58% | 44.51 34.67% | 49.15 10.42% | 60.36 22.80% | 68.96 14.25% | |
ev to operating cash flow | -3.41K - | -50.35 98.53% | 50.55 200.39% | 61.00 20.67% | 254.20 316.72% | 88.29 65.27% | 67.92 23.07% | 68.55 0.93% | 58.93 14.04% | 131.02 122.34% | |
ev to sales | 5.82 - | 4.91 15.72% | 5.47 11.54% | 4.33 20.85% | 3.91 9.65% | 6.67 70.34% | 7.14 7.10% | 8.88 24.44% | 7.37 17.00% | 7.62 3.29% | |
free cash flow per share | -8.98 - | -27.80 209.72% | 19.18 168.98% | 13.07 31.85% | 1.00 92.32% | 14.52 1,345.82% | 29.28 101.71% | 38.83 32.61% | 36.47 6.07% | 19.91 45.40% | |
free cash flow yield | -0.01 - | -0.03 271.59% | 0.02 155.01% | 0.01 15.86% | 0.00 92.35% | 0.01 575.37% | 0.01 68.74% | 0.01 5.93% | 0.01 10.77% | 0.01 57.17% | |
graham net net | -17.09 - | -31.87 86.44% | -19.89 37.60% | 2.33 111.72% | 6.68 186.70% | 15.88 137.60% | 25.94 63.37% | 75.11 189.52% | 103.75 38.14% | 116.28 12.07% | |
graham number | 17.73 - | 106.35 499.80% | 54.35 48.90% | 126.01 131.86% | 151.77 20.44% | 242.82 60.00% | 307.80 26.76% | 391.43 27.17% | 336.76 13.97% | 458.76 36.23% | |
income quality | 1.59 - | 2.19 38.19% | 9.89 350.88% | 1.15 88.33% | 0.20 82.61% | 0.76 276.99% | 0.77 1.38% | 0.82 7.48% | 1.21 47.23% | 0.43 64.19% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 Infinity% | |
interest coverage | 100.72 - | 115.95 15.13% | 85.75 26.05% | 149.26 74.06% | |||||||
interest debt per share | 0.11 - | 0.11 0% | 5.19 - | 5.29 1.93% | 3.83 27.59% | 3.14 18.09% | |||||
inventory turnover | 1.88 - | 2.36 25.25% | 2.77 17.70% | 3.50 26.10% | 1.98 43.51% | 2.28 15.56% | 2.02 11.32% | 2.07 2.16% | 2.55 23.25% | 2.41 5.61% | |
invested capital | 0.00 - | 0.00 13.82% | 0.03 - | 0.03 18.08% | 0.02 36.59% | 0.01 27.39% | |||||
market cap | 27.62B - | 23.02B 16.65% | 28.87B 25.39% | 23.38B 19.01% | 23.48B 0.44% | 50.27B 114.08% | 60.10B 19.54% | 75.23B 25.19% | 63.80B 15.20% | 81.31B 27.46% | |
net current asset value | 286.44M - | 24.23M 91.54% | 185.77M 666.69% | 554.81M 198.65% | 1.07B 93.42% | 1.44B 33.93% | 2.00B 39.44% | 3.00B 49.81% | 3.60B 20.08% | 4.39B 21.86% | |
net debt to ebitda | 0.15 - | 0.25 62.50% | -0.37 251.07% | -0.03 91.93% | -2.25 7,400.72% | -2.43 8.15% | -0.54 77.91% | -2.33 333.36% | -4.47 91.97% | -4.45 0.38% | |
net income per share | -0.20 - | -8.34 3,994.91% | 2.10 125.24% | 9.78 364.77% | 10.36 6.00% | 21.78 110.15% | 28.88 32.62% | 37.32 29.21% | 24.64 33.98% | 39.72 61.20% | |
operating cash flow per share | -0.32 - | -18.28 5,558.68% | 22.80 224.70% | 15.32 32.78% | 3.52 77.05% | 21.99 525.48% | 34.97 59.00% | 41.91 19.86% | 40.32 3.80% | 23.32 42.16% | |
payables turnover | 1.64 - | 1.82 11.24% | 2.25 23.30% | 5.64 150.92% | 2.34 58.45% | 1.60 31.63% | 1.59 0.54% | 1.85 16.23% | 1.90 2.57% | 2.01 5.67% | |
receivables turnover | 5.41 - | 3.08 43.02% | 4.62 50.00% | 6.78 46.63% | 8.91 31.42% | 7.98 10.36% | 8.70 8.97% | 8.86 1.88% | 8.20 7.53% | 9.32 13.72% | |
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -0.00 - | -0.05 4,034.65% | 0.01 125.60% | 0.06 399.19% | 0.06 13.05% | 0.10 72.27% | 0.10 5.48% | 0.12 17.81% | 0.07 40.29% | 0.10 41.28% | |
revenue per share | 189.50 - | 187.62 0.99% | 210.58 12.24% | 215.83 2.49% | 228.40 5.82% | 291.30 27.54% | 332.71 14.22% | 323.42 2.79% | 322.24 0.37% | 401.22 24.51% | |
roe | -0.00 - | -0.14 4,560.97% | 0.03 124.38% | 0.14 301.82% | 0.10 22.53% | 0.18 72.51% | 0.20 9.46% | 0.20 3.22% | 0.12 41.11% | 0.17 40.02% | |
roic | -0.23 - | -0.00 98.22% | 0.08 2,097.71% | 0.08 1.90% | 0.14 71.76% | 0.19 33.47% | 0.19 3.03% | 0.11 40.81% | 0.12 1.50% | ||
sales general and administrative to revenue | 0.04 - | 0.04 3.75% | 0.03 18.91% | 0.03 0.02% | 0.02 28.85% | 0.03 48.80% | 0.03 1.59% | 0.03 1.97% | 0.03 8.37% | 0.03 2.87% | |
shareholders equity per share | 68.64 - | 60.30 12.14% | 62.41 3.49% | 72.18 15.67% | 98.77 36.84% | 120.32 21.82% | 145.78 21.16% | 182.47 25.17% | 204.56 12.11% | 235.49 15.12% | |
stock based compensation to revenue | 0.00 - | 0.00 13.39% | 0.00 3.22% | 0.00 35.94% | 0.00 23.42% | 0.00 4.66% | |||||
tangible asset value | 1.72B - | 1.51B 12.14% | 1.56B 3.49% | 1.80B 15.67% | 2.47B 36.84% | 3.01B 21.82% | 3.64B 21.16% | 4.56B 25.17% | 5.11B 12.11% | 5.81B 13.62% | |
tangible book value per share | 68.64 - | 60.30 12.14% | 62.41 3.49% | 72.18 15.67% | 98.77 36.84% | 120.32 21.82% | 145.78 21.16% | 182.47 25.17% | 204.56 12.11% | 235.49 15.12% | |
working capital | 291.33M - | 34.42M 88.19% | 198.44M 476.54% | 679.01M 242.17% | 1.14B 67.85% | 1.46B 27.88% | 2.15B 47.58% | 3.15B 46.58% | 3.73B 18.32% | 4.52B 21.05% |
All numbers in INR (except ratios and percentages)